# Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia

> clinical trial · VERIFIED · 2026-08-19

Status: RECRUITING · Sponsor: Quetzal Therapeutics · Condition: Acute Promyelocytic Leukemia (APL)

- Company: Quetzal Therapeutics
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT07504458

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.